2021 European Society for Medical Oncology (ESMO) World Congress on GI Cancer
Course The ESMO World Congress on Gastrointestinal Cancer represents the year’s premier gathering of international oncology professionals who are dedicated to improving the lives of patients impacted by diseases of the GI tract. The Congress is the leading global...
Course The ESMO World Congress on Gastrointestinal Cancer represents the year’s premier gathering of international oncology professionals who are dedicated to improving the lives of patients impacted by diseases of the GI tract. The Congress is the leading global platform for discussing the latest emerging data and new research in this rapidly advancing scientific field. We are happy to announce that we will return to Barcelona for a face-to-face meeting in 2021. Highlights: As the premier global gathering in the field, the Congress brings together leading gastroenterology, oncology, pathology, and hepatology experts, clinicians, and surgeons, as well as clinical researchers from across the globe to share pioneering research, approaches, and best practices in treating patients with cancers of the gastrointestinal tract. ,The program provides all stakeholders with opportunities to learn, debate, discuss, and network in this very active scientific field where recent progress has led to improvements in patient outcomes. ,Learning Objectives: After attending this Congress, participants should be able to: • Identify current controversies in the management of patients with gastric or esophageal cancers • Discuss contemporary treatment options for patients with gastric or esophageal cancers • Comment on available treatment options for rare gastrointestinal and neuroendocrine tumors • Describe the epidemiology and pathogenesis of hepatocellular carcinoma • Discuss management of patients with cancer of the liver • Identify adjuvant and neoadjuvant treatment options for patients with locally advanced and metastatic cancer of the pancreas • Select the most appropriate detection, screening, and chemoprevention methods for colorectal cancer • Describe the use of molecular markers for screening and prognosis of colorectal cancer and gastric cancer • Select the most appropriate adjuvant and neoadjuvant treatments for colorectal cancer patients • Comment on new agents in the treatment of colorectal cancer and the latest clinical trials results • Identify treatment strategies for rectal cancer • Distinguish appropriate surgical techniques for the treatment of gastrointestinal cancer ,Additional details will be posted as soon as information is available.